68 results
8-K
EX-1.1
ADIL
Adial Pharmaceuticals Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:27pm
or potential defendants in, or targets of, any such action include both the indemnified party and the indemnifying party and the indemnified party shall
8-K
EX-10.2
ADIL
Adial Pharmaceuticals Inc
18 Jan 24
Adial Announces Appointment of Tony Goodman as Chief Operating Officer
4:15pm
, intellectual property, facilities and HR, and partner with CEO to align functions with Adial’s corporate objectives and overall plan targets both near
8-K
EX-99.1
ADIL
Adial Pharmaceuticals Inc
11 Sep 23
Regulation FD Disclosure
6:03am
of AD04 assuming a successful regulatory outcome Primary Targets - companies with commercial capabilities or pipeline development capabilities … in: Alcohol Therapeutics, Addiction, Psychiatry, Neurology, and niche Orphan CNS Secondary Targets - companies focused on DTP (Direct to Patient) and DTC
424B3
vuo04oq
28 Jul 23
Prospectus supplement
6:13pm
8-K
EX-99.1
wafvd9zpug5
9 Jun 23
Regulation FD Disclosure
12:15pm
POS AM
6091tpb03udu
24 Jun 22
Prospectus update (post-effective amendment)
5:11pm
POS AM
l1v3w5bgjni
24 Jun 22
Prospectus update (post-effective amendment)
5:02pm
8-K
EX-99.1
23i45
16 May 22
Adial Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
9:25am
424B3
rztvcyl5
12 Apr 22
Prospectus supplement
4:15pm
424B5
8y5otql
14 Feb 22
Prospectus supplement for primary offering
4:55pm
424B3
e6sk2e
17 Dec 21
Prospectus supplement
12:00am